Dimitrios Trafalis
Overview
Explore the profile of Dimitrios Trafalis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Thysiadis S, Katsamakas S, Dalezis P, Chatzisideri T, Trafalis D, Sarli V
Future Med Chem
. 2017 Nov;
9(18):2181-2196.
PMID: 29110537
Aim: Alkylating agents and antimetabolites are cytotoxic drugs commonly used in cancer treatment. These medications are often associated with serious side effects on normal tissues and organs. Methodology: To improve...
12.
Stathopoulos G, Trafalis D, Kaparelou M
J BUON
. 2016 Sep;
21(4):1013-1015.
PMID: 27685927
Purpose: Bone metastases in breast cancer are quite common, and some patients may have no other site of metastasis. An effective treatment is often endocrine agents administration (tamoxifen or antiaromatases),...
13.
Trafalis D, Geromichalou E, Dalezis P, Nikoleousakos N, Sarli V
Steroids
. 2016 Jul;
115:1-8.
PMID: 27473822
Alkylating agents are still nowadays one of the most important classes of cytotoxic drugs, which display a wide range of therapeutic use for the treatment of various cancers. We have...
14.
Stathopoulos G, Ardavanis A, Papakotoulas P, Pectasides D, Papadopoulos G, Antoniou D, et al.
Anticancer Drugs
. 2009 Dec;
21(2):202-5.
PMID: 20010424
Oral topotecan has been recently brought into clinical practice at a dose of 2.3 mg/m(2) for 5 days, every 3 weeks. Published data show quite high myelotoxicity. The aim of...
15.
Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, Margaritis G, Christofilakis C
Int J Urol
. 2005 Sep;
12(8):757-9.
PMID: 16174051
Cholestasis, as a paraneoplastic syndrome, has been well described in patients with malignant lymphohyperplastic diseases and renal cell cancer. Non-metastatic nephrogenic hepatic dysfunction syndrome without jaundice has often been described...
16.
Camoutsis C, Trafalis D, Pairas G, Papageorgiou A
Farmaco
. 2005 Sep;
60(10):826-9.
PMID: 16139280
The p-[N,N-bis(2-chloroethyl)amino]phenylacetic acid esters of hecogenin and aza-homo-hecogenin have been prepared and their antineoplastic activity was evaluated against two basic drug screening systems in rodents, P388 lymphocytic and L1210 lymphoid...
17.
Nakopoulou L, Tsirmpa I, Giannopoulou I, Trafalis D, Katsarou S, Davaris P
Cancer Genet Cytogenet
. 2002 May;
134(2):127-32.
PMID: 12034525
Breast carcinoma is a genetically and phenotypically heterogeneous disease and is frequently associated with nonrandom chromosomal alterations. The aim of this study was to investigate the numerical aberrations of chromosome...
18.
Nakopoulou L, Giannopoulou I, Trafalis D, Gakiopoulou H, Keramopoulos A, Davaris P
Appl Immunohistochem Mol Morphol
. 2002 Mar;
10(1):20-8.
PMID: 11893031
Breast cancer is a genetically complex disease and is frequently associated with nonrandom chromosomal alterations. The occurrence of aberrations involving chromosomes 1 and 17 in malignant tissues of breast cancer...